Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Marco J Haenssgen discusses the application of management thinking to solving the growing global problem of antimicrobial resistance.

You may have heard about superbugs, drug-resistant bacteria, or antibiotic and antimicrobial resistance (AMR) – all referring to one of the most pressing health challenges that the world is facing currently. AMR is high on public health agendas, it has attracted several hundreds of millions of pounds of research funding, and it risks to become one of the leading causes of death in the world by claiming an estimated 10 million lives annually by 2050The World Bank argues that this will have an economic impact similar to the 2008 global financial crisis. Poor countries will be hit hardest, but rich countries are by no means safe because drug resistance is a global problem and drug-resistant bacteria can also be imported from abroad. The UK experienced this very recently, for example.

Read more (Oxford Science Blog)

Similar stories

Researchers develop machine learning algorithm to diagnose deep vein thrombosis

A team of researchers are developing the use of an artificial intelligence (AI) algorithm with the aim of diagnosing deep vein thrombosis (DVT) more quickly and as effectively as traditional radiologist-interpreted diagnostic scans, potentially cutting down long patient waiting lists and avoiding patients unnecessarily receiving drugs to treat DVT when they don’t have it.

COVID-19 recovery project nominated for HSJ award

The project, involving Oxford University Hospitals, Defence Medical Services (DMS), and the Radcliffe Department of Medicine is in the running for a prestigious honour at the Health Service Journal Awards 2021.

Oxford to assess revolutionary multi-cancer blood test in trial, for future implementation in the NHS

A partnership between the University of Oxford and GRAIL, LLC will evaluate the use of a new, non-invasive, multi-cancer early detection test known as Galleri in suspected cancer patients.

Blood bank storage can reduce ability of transfusions to treat anaemia

New research from Department of Physiology, Anatomy & Genetics (DPAG), in collaboration with NHS Blood and Transplant, has demonstrated that the process of storing blood in blood banks can negatively impact the function of red blood cells and consequently may reduce the effectiveness of blood transfusions, a treatment commonly used to combat anaemia.